journal
MENU ▼
Read by QxMD icon Read
search

Journal of Clinical Psychopharmacology

journal
https://read.qxmd.com/read/30747752/effects-of-curcumin-on-cognitive-functioning-and-inflammatory-state-in-schizophrenia-a-double-blind-placebo-controlled-pilot-trial
#1
Suat Kucukgoncu, Sinan Guloksuz, Cenk Tek
No abstract text is available yet for this article.
February 8, 2019: Journal of Clinical Psychopharmacology
https://read.qxmd.com/read/30742591/attentional-bias-cool-and-hot-executive-functions-in-obese-patients-roles-of-body-mass-index-binge-eating-and-eating-style
#2
Ching-Tzu Fang, Vincent Chin-Hung Chen, Hsiang-Ting Ma, Hse-Huang Chao, Ming-Chou Ho, Michael Gossop
PURPOSE/BACKGROUND: Obesity is recognized as an important risk factor for many chronic diseases and is a major health issue. The current study examined attentional bias to food and the "cool" (inhibitory control and mental flexibility) and "hot" (affective decision making) executive functions (EFs) in obese patients preparing for bariatric surgery. In addition to body mass index (BMI), this study examined the impact of the binge-eating tendency and eating styles. METHODS: The study population comprised 21 morbidly obese patients preparing to undergo bariatric surgery (BMI ≥30 kg/m) and 21 normal-weight controls (24 kg/m > BMI ≥ 18...
February 7, 2019: Journal of Clinical Psychopharmacology
https://read.qxmd.com/read/30742590/effects-of-cytochrome-p450-2c19-genetic-polymorphisms-on-responses-to-escitalopram-and-levels-of-brain-derived-neurotrophic-factor-in-patients-with-panic-disorder
#3
Qianqian He, Yan Mei, Yuanyuan Liu, Zhuo Yuan, Jian Zhang, Hong Yan, Li Shen, Yong Zhang
PURPOSE/BACKGROUND: The purpose of this study was to examine the relationships between ytochrome P450 family 2 subfamily C member 19 (CYP2C19) polymorphisms, brain-derived neurotrophic factor (BDNF) plasma levels, and treatment responses to escitalopram in Chinese patients with panic disorder (PD). METHODS/PROCEDURES: Ninety patients with PD were administered the Panic Disorder Severity Scale-Chinese Version (PDSS-CV) and Hamilton Anxiety Scale (HAMA-14) from baseline to 8 weeks...
February 7, 2019: Journal of Clinical Psychopharmacology
https://read.qxmd.com/read/30742589/effects-of-repeated-intravenous-ketamine-in-treatment-resistant-geriatric-depression-a-case-series
#4
Kelly A Bryant, Murat Altinay, Nora Finnegan, Kim Cromer, Roman M Dale
PURPOSE: There is an immediate need for more sustainable, effective therapies for treatment-resistant depression in patients who do not respond to traditional psychopharmacology. The aim of this study was to determine the efficacy and safety of intravenous ketamine infusions on the elderly population by using a case series of 6 geriatric patients with treatment-resistant depression. METHODS: Eligible patients aged 65 to 82 were given a subanesthetic ketamine hydrochloride dose of 0...
February 7, 2019: Journal of Clinical Psychopharmacology
https://read.qxmd.com/read/30724761/statistics-commentary-series-commentary-no-31-the-uses-and-misuses-of-the-analysis-of-covariance
#5
David L Streiner
No abstract text is available yet for this article.
February 4, 2019: Journal of Clinical Psychopharmacology
https://read.qxmd.com/read/30707118/pharmacokinetics-and-pharmacodynamics-of-immediate-release-versus-extended-release-guanfacine-in-adult-daily-smokers
#6
Terril L Verplaetse, Walter Roberts, Kelly E Moore, MacKenzie R Peltier, Lindsay M Oberleitner, Sherry A McKee
BACKGROUND: Guanfacine is Food and Drug Administration approved for hypertension and attention-deficit hyperactivity disorder and has been used off-label for migraine prophylaxis, heroin withdrawal, and more recently smoking cessation. Previous studies have shown positive effects of 3 mg/d of immediate-release (IR) guanfacine on smoking outcomes, but the dose equivalency of the IR and extended-release (ER) formulations is unknown. PROCEDURES: A within-subject design was used to compare the pharmacokinetics and pharmacodynamics of 3 mg/d of IR, 4 mg/d of ER, and 6 mg/d of ER guanfacine in adult daily smokers (n = 5)...
January 30, 2019: Journal of Clinical Psychopharmacology
https://read.qxmd.com/read/30694881/milk-thistle-treatment-for-children-and-adults-with-trichotillomania-a-double-blind-placebo-controlled-crossover-negative-study
#7
Jon E Grant, Sarah A Redden, Samuel R Chamberlain
BACKGROUND: Data on the pharmacological treatment of trichotillomania are limited. Milk thistle has antioxidant properties and showed promise in trichotillomania in a prior case report. The goal of the current study was to determine the efficacy and tolerability of silymarin in children and adults with trichotillomania. METHODS: Twenty individuals (19 [95.0%] women; 16 adults; mean age, 27.9 [11.5] years) with trichotillomania entered a 12-week, double-blind, placebo-controlled crossover study (6 weeks of milk thistle and 6 weeks of placebo with a 1-week wash-out in between)...
January 28, 2019: Journal of Clinical Psychopharmacology
https://read.qxmd.com/read/30640795/late-onset-cholestatic-liver-injury-during-combination-treatment-with-chlorpromazine-and-olanzapine-a-case-report
#8
Nicola Dusi, Carla Comacchio, Antonio Lasalvia
No abstract text is available yet for this article.
January 11, 2019: Journal of Clinical Psychopharmacology
https://read.qxmd.com/read/30640209/ziprasidone-augmentation-of-ssri-antidepressants-in-posttraumatic-stress-disorder-a-randomized-placebo-controlled-pilot-study-of-augmentation-therapy
#9
Mark B Hamner, Melba A Hernandez-Tejada, Zachary D Zuschlag, Deborah Agbor-Tabi, Michael Huber, Zhewu Wang
BACKGROUND: Posttraumatic stress disorder (PTSD) is often a chronic, disabling illness for which antidepressant medications (ie, SSRI) are considered the primary psychopharmacological treatment. However, many patients remain refractory to antidepressants alone or in combination with psychotherapy. Safe and effective treatments for individuals with refractory PTSD are needed. This study aimed to examine ziprasidone augmentation of SSRI treatment of PTSD. METHODS: This was a 2-phase study...
January 10, 2019: Journal of Clinical Psychopharmacology
https://read.qxmd.com/read/30628997/dose-dependent-efficacy-of-tandospirone-for-an-oldest-old-patient-with-behavioral-and-psychological-symptoms-of-dementia
#10
Shinichiro Ochi, Takaaki Mori, Jun-Ichi Iga, Shu-Ichi Ueno
No abstract text is available yet for this article.
January 8, 2019: Journal of Clinical Psychopharmacology
https://read.qxmd.com/read/30624300/low-dose-aripiprazole-associated-sleepwalking-in-a-long-term-zolpidem-treatment-patient-with-a-depressive-episode-a-case-report
#11
Ching-Wen Chu, Chih-Sung Liang
No abstract text is available yet for this article.
January 7, 2019: Journal of Clinical Psychopharmacology
https://read.qxmd.com/read/30811377/low-incidence-of-neuroleptic-malignant-syndrome-associated-with-paliperidone-palmitate-long-acting-injectable-a-database-report-and-case-study
#12
John M Kane, Christoph U Correll, Nicholas Delva, Srihari Gopal, Adam Savitz, Maju Mathews
No abstract text is available yet for this article.
March 2019: Journal of Clinical Psychopharmacology
https://read.qxmd.com/read/30811376/methylphenidate-induced-raynaud-phenomenon-developed-after-increasing-methylphenidate-in-an-adult-with-attention-deficit-hyperactivity-disorder
#13
Yuwarat Monteerarat, Pornjira Pariwatcharakul
No abstract text is available yet for this article.
March 2019: Journal of Clinical Psychopharmacology
https://read.qxmd.com/read/30811375/venlafaxine-abuse-in-a-patient-with-a-history-of-methylphenidate-abuse-a-case-report
#14
Thomas Iliou, Pauline Casta, Judy Lequeux, Liselotte Pochard, Elisabeth Frauger, Michel Spadari, Joëlle Micallef
No abstract text is available yet for this article.
March 2019: Journal of Clinical Psychopharmacology
https://read.qxmd.com/read/30811374/extended-requirement-of-granulocyte-colony-stimulating-factor-for-clozapine-associated-neutropenia
#15
Idris E Leppla, Frederick C Nucifora, Thomas W Sedlak
No abstract text is available yet for this article.
March 2019: Journal of Clinical Psychopharmacology
https://read.qxmd.com/read/30811373/abrupt-decrease-of-clozapine-plasma-concentration-after-discontinuation-of-flupentixol-comedication
#16
Xenija Wagner, Michael Kluge
No abstract text is available yet for this article.
March 2019: Journal of Clinical Psychopharmacology
https://read.qxmd.com/read/30811372/clozapine-metabolism-in-east-asians-and-caucasians-a-pilot-exploration-of-the-prevalence-of-poor-metabolizers-and-a-systematic-review
#17
Can-Jun Ruan, Yan-Nan Zang, Chuan-Yue Wang, Yu-Hang Cheng, Chuan Sun, Edoardo Spina, Jose de Leon
PURPOSE/BACKGROUND: In clozapine therapeutic drug monitoring (TDM) studies, Chinese reached the same concentrations using half the dosage Caucasians use. Defining clozapine poor metabolizers (PMs) requires stratification by ethnicity, smoking, and sex. METHODS/PROCEDURES: After sex and smoking stratification in 129 Chinese inpatients (mean, 8.8 TDM samples per patient), we explored the association between the total concentration-dose (C/D) ratio and CYP1A2 (*1C, *1F, and *7) and CYP2C19 alleles (*2 and *3)...
March 2019: Journal of Clinical Psychopharmacology
https://read.qxmd.com/read/30811371/neuropsychiatric-safety-and-efficacy-of-varenicline-bupropion-and-nicotine-patch-in-smokers-with-psychotic-anxiety-and-mood-disorders-in-the-eagles-trial
#18
A Eden Evins, Neal L Benowitz, Robert West, Cristina Russ, Thomas McRae, David Lawrence, Alok Krishen, Lisa St Aubin, Melissa Culhane Maravic, Robert M Anthenelli
BACKGROUND: Neuropsychiatric safety and relative efficacy of varenicline, bupropion, and transdermal nicotine patch (NRT) in those with psychiatric disorders are of interest. METHODS: We performed secondary analyses of safety and efficacy outcomes by psychiatric diagnosis in EAGLES (Evaluating Adverse Events in a Global Smoking Cessation Study), a 12-week, randomized, double-blind, triple-dummy, placebo- and active (NRT)-controlled trial of varenicline and bupropion with 12-week follow-up, in a subset population, n = 4092, with a primary psychotic (n = 390), anxiety (n = 792), or mood (n = 2910) disorder...
March 2019: Journal of Clinical Psychopharmacology
https://read.qxmd.com/read/30811370/article-selected-for-the-mitchell-b-balter-award-2018
#19
(no author information available yet)
No abstract text is available yet for this article.
March 2019: Journal of Clinical Psychopharmacology
https://read.qxmd.com/read/30762602/seven-aphorisms-about-therapeutic-relationships-and-listening
#20
Richard I Shader
No abstract text is available yet for this article.
March 2019: Journal of Clinical Psychopharmacology
journal
journal
28217
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"